The prognostic value of the miR-141/YAP1 pathway was also proved by analyzing the association between miR-141 expression and clinical outcomes in pancreatic ductal adenocarcinoma patients [67]. The gene discussed is YAP1; the disease is pancreatic ductal adenocarcinoma.